Volume 21, Issue 8 (November 2023)                   Nursing and Midwifery Journal 2023, 21(8): 600-602 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shamsikhani S, Hosseini M. PROBIOTIC BACILLUS COAGULANS: A RAY OF HOPE FOR BETTER HEALTH. Nursing and Midwifery Journal 2023; 21 (8) :600-602
URL: http://unmf.umsu.ac.ir/article-1-4990-en.html
1- PhD in Nursing, Shazand School of Nursing, Arak University of Medical Sciences, Arak, Iran
2- Nursing Master's student, Student Research Committee, Arak University of Medical Sciences, Arak, Iran (Corresponding Author) , smahsahosseini99@gmail.com
Abstract:   (413 Views)
Dear Editor,
Live microorganisms called probiotics have beneficial effects on the host's health (1). Probiotic Bacillus coagulan has received more attention than others. Hammer first isolated it from contaminated canned milk in 1915 (2). In research, this probiotic has demonstrated unique properties and benefits.
1.Resistance: This probiotic is very resistant to techniques for food preparation, like boiling and cooking, so it is a good choice for use in food companies (3). Also, this probiotic was found to not adversely affect the nutritional and sensory properties of the product (4).
2.Genome: One of the essential advantages of this type of probiotic is that it is almost impossible to transmit antibiotic resistance genes to the next generation, and they can recover the genes if at risk (5).
3. Microbiota: Many diseases are associated with an imbalance in the Microbiota, so balance helps maintain health and treat disease (6). Probiotics have been shown by many studies to be essential in maintaining human immunological homeostasis. It also received much attention in this field because of its strong regulatory effect on the host microbiota and immune response, with little concern for harm or risk from ingestion (7).
4. reactive oxygen species(ROS): This Probiotic, through different methods, can increase human immunity, including the ability to produce a variety of active radicals (8).
5. Immunity and Inflammation: Ingestion of Bacillus coagulans can markedly regulate inflammatory immune factors such as interferon-gamma (IFNγ), interleukin (IL), and tumor necrosis factor (TNF) without altering natural cytokines. This probiotic can produce immune-activating cytokines, anti-inflammatory, chemokines, and growth factors (7).
6. PH: Various research shows that probiotics positively affect natural flora, but they are highly sensitive to acidic environments, while some probiotic species have high resistance in these conditions (9, 10). And even with a decreased pH, it can make the environment unfavorable for other microorganisms (11).
Finally, due to the extensive and beneficial effects of this probiotic and its effect on the oxidative stress process, it seems that the use of its products can affect the prevention, improvement, treatment and rehabilitation of many chronic diseases. Also according to
The significant effect of Bacillus coagulan on the host's immune system and according to some evidence supporting the various effects of this probiotic may be useful in the management and reduction of human diseases.
Full-Text [PDF 398 kb]   (127 Downloads)    
Type of Study: Letter to editor | Subject: متفرقه

References
1. Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods 2019;8(3):92. [DOI:10.3390/foods8030092] [PMID] []
2. Weerkamp A. Thermophilic bacteria. Biosystems 1974;6(1):69-70. [DOI:10.1016/0303-2647(74)90023-9]
3. Fares C, Menga V, Martina A, Pellegrini N, Scazzina F, Torriani S. Nutritional profile and cooking quality of a new functional pasta naturally enriched in phenolic acids, added with β-glucan and Bacillus coagulans GBI-30, 6086. J Cereal Sci 2015;65:260-6. [DOI:10.1016/j.jcs.2015.07.017]
4. Kobus-Cisowska J, Szymanowska D, Maciejewska P, Szczepaniak O, Kmiecik D, Gramza-Michałowska A, et al. Enriching novel dark chocolate with Bacillus coagulans as a way to provide beneficial nutrients. Food Func 2019;10(2):997-1006. [DOI:10.1039/C8FO02099J] [PMID]
5. Salvetti E, Orrù L, Capozzi V, Martina A, Lamontanara A, Keller D, et al. Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study. Appl Microbiol Biotechnol 2016;100(10):4595-605. [DOI:10.1007/s00253-016-7416-9] [PMID]
6. Scott KP, Jean-Michel A, Midtvedt T, van Hemert S. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis 2015;26(1):25877. [DOI:10.3402/mehd.v26.25877] [PMID] []
7. Cao J, Yu Z, Liu W, Zhao J, Zhang H, Zhai Q, et al. Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases. J Funct Foods 2020; 64:103643. [DOI:10.1016/j.jff.2019.103643]
8. Gong D, Wilson PW, Bain MM, McDade K, Kalina J, Hervé-Grépinet V, et al. Gallin; an antimicrobial peptide member of a new avian defensin family, the ovodefensins, has been subject to recent gene duplication. BMC Immunol 2010;11(1):1-15. [DOI:10.1186/1471-2172-11-12] [PMID] []
9. Dolin B. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Findings Experim Clin Pharmacol 2009;31(10):655-9. [DOI:10.1358/mf.2009.31.10.1441078] [PMID]
10. Endres J, Clewell A, Jade K, Farber T, Hauswirth J, Schauss A. Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 2009;47(6):1231-8. [DOI:10.1016/j.fct.2009.02.018] [PMID] []
11. Jensen GS, Benson KF, Carter SG, Endres JR. GanedenBC30™ cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro. BMC Immunol 2010;11(1):1-14. [DOI:10.1186/1471-2172-11-15] [PMID] []

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Nursing And Midwifery Journal

Designed & Developed by : Yektaweb